Spurred by George Schett and Andreas Mackensen’s remarkable CAR-T results in SLE, the immunotherapy revolution for autoimmune diseases is the next “million-dollar question”.
60+ attending companies across modalities so pharma can decide which horse to back in this quickly evolving space
1-2-1 meetings bookable via the partnering portal for efficient and high yielding conversations between decision makers
15 big pharma leads across business development, search and evaluation, immunology research and venture giving the best, most comprehensive opportunity to meet the full teams assessing due diligence and asset synergy
100% alignment on interests and intentions, increasing the surface area for synergy in research and collaboration goals
Secure your place here or get in touch with the team – info@hansonwade.com